Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism

Saved in:
Bibliographic Details
Main Authors: Daniella Veloria, Benjamin Wang, Ran Ran, David Ha, Robert Diep, Calvin Diep
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Thrombosis Update
Online Access:http://www.sciencedirect.com/science/article/pii/S2666572725000021
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583061267546112
author Daniella Veloria
Benjamin Wang
Ran Ran
David Ha
Robert Diep
Calvin Diep
author_facet Daniella Veloria
Benjamin Wang
Ran Ran
David Ha
Robert Diep
Calvin Diep
author_sort Daniella Veloria
collection DOAJ
format Article
id doaj-art-f58cca81a00940d188168fe7607c623c
institution Kabale University
issn 2666-5727
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Thrombosis Update
spelling doaj-art-f58cca81a00940d188168fe7607c623c2025-01-29T05:02:13ZengElsevierThrombosis Update2666-57272025-03-0118100199Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolismDaniella Veloria0Benjamin Wang1Ran Ran2David Ha3Robert Diep4Calvin Diep5Department of Pharmacy, Stanford Health Care, Palo Alto, CA, United States; Corresponding author.Department of Pharmacy, Stanford Health Care, Palo Alto, CA, United StatesDepartment of Emergency & Critical Care Medicine, Oregon Health & Science University, Portland, OR, United StatesDivision of Infectious Diseases and Geographic Medicine, Stanford University, United StatesDivision of Hematology, Stanford University, Palo Alto, CA, United StatesDepartment of Pharmacy, Stanford Health Care, Palo Alto, CA, United Stateshttp://www.sciencedirect.com/science/article/pii/S2666572725000021
spellingShingle Daniella Veloria
Benjamin Wang
Ran Ran
David Ha
Robert Diep
Calvin Diep
Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism
Thrombosis Update
title Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism
title_full Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism
title_fullStr Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism
title_full_unstemmed Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism
title_short Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism
title_sort reduced versus full apixaban lead in dosing following parenteral treatment of acute venous thromboembolism
url http://www.sciencedirect.com/science/article/pii/S2666572725000021
work_keys_str_mv AT daniellaveloria reducedversusfullapixabanleadindosingfollowingparenteraltreatmentofacutevenousthromboembolism
AT benjaminwang reducedversusfullapixabanleadindosingfollowingparenteraltreatmentofacutevenousthromboembolism
AT ranran reducedversusfullapixabanleadindosingfollowingparenteraltreatmentofacutevenousthromboembolism
AT davidha reducedversusfullapixabanleadindosingfollowingparenteraltreatmentofacutevenousthromboembolism
AT robertdiep reducedversusfullapixabanleadindosingfollowingparenteraltreatmentofacutevenousthromboembolism
AT calvindiep reducedversusfullapixabanleadindosingfollowingparenteraltreatmentofacutevenousthromboembolism